Published in Pathophysiol Haemost Thromb on September 24, 2003
Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease. World J Gastroenterol (2012) 1.17
Abnormalities in the fatty-acid composition of the serum phospholipids of stroke patients. J Natl Med Assoc (2004) 0.81
BRIEF REPORT: nutrition and weight loss information in a popular diet book: is it fact, fiction, or something in between? J Gen Intern Med (2006) 0.75
Early psoriatic arthritis: the clinical spectrum. J Rheumatol (2007) 1.79
Drug-induced liver injury: is it somehow foreseeable? World J Gastroenterol (2009) 1.18
Young adult obese subjects with and without insulin resistance: what is the role of chronic inflammation and how to weigh it non-invasively? J Inflamm (Lond) (2009) 1.13
Differences of myocardial systolic deformation and correlates of diastolic function in competitive rowers and young hypertensives: a speckle-tracking echocardiography study. J Am Soc Echocardiogr (2010) 1.09
Treatment of hemophilia: a review of current advances and ongoing issues. J Blood Med (2010) 1.07
Bariatric surgery and diabetes remission: sleeve gastrectomy or mini-gastric bypass? World J Gastroenterol (2013) 1.00
Nail and distal interphalangeal joint in psoriatic arthritis. J Rheumatol (2006) 1.00
Inherited thrombophilia: implications for prevention and treatment of venous thromboembolism. Semin Thromb Hemost (2009) 1.00
Long-term outcomes of patients with cerebral vein thrombosis: a multicenter study. J Thromb Haemost (2012) 0.99
Disseminated intravascular coagulation in hematologic malignancies. Semin Thromb Hemost (2010) 0.98
Predictors of early minimal disease activity in patients with psoriatic arthritis treated with tumor necrosis factor-α blockers. J Rheumatol (2012) 0.98
Obesity and psoriatic arthritis: from pathogenesis to clinical outcome and management. Rheumatology (Oxford) (2012) 0.96
The effectiveness of a traditional therapeutical approach in early psoriatic arthritis: results of a pilot randomised 6-month trial with methotrexate. Clin Rheumatol (2007) 0.94
Effects of treatment with metformin on TSH levels: a meta-analysis of literature studies. J Clin Endocrinol Metab (2013) 0.91
Prevention of venous thromboembolism in medical patients with thrombocytopenia or with platelet dysfunction: a review of the literature. Semin Thromb Hemost (2011) 0.91
Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery. Cochrane Database Syst Rev (2015) 0.90
Troponin I and right ventricular dysfunction for risk assessment in patients with nonmassive pulmonary embolism in the Emergency Department in combination with clinically based risk score. Intern Emerg Med (2008) 0.90
Acquired inhibitors of coagulation factors: part I-acquired hemophilia A. Semin Thromb Hemost (2012) 0.90
Filling the gap between science & clinical practice: prevention of stroke recurrence. Thromb Res (2011) 0.90
Hepatic steatosis, carotid plaques and achieving MDA in psoriatic arthritis patients starting TNF-α blockers treatment: a prospective study. Arthritis Res Ther (2012) 0.90
Tissue factor and atherosclerosis: not only vessel wall-derived TF, but also platelet-associated TF. Thromb Res (2011) 0.90
Computed tomography findings of pneumatosis and portomesenteric venous gas in acute bowel ischemia. World J Gastroenterol (2013) 0.89
Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study. Am J Hematol (2012) 0.89
Wernicke encephalopathy in subjects undergoing restrictive weight loss surgery: a systematic review of literature data. Eur Eat Disord Rev (2014) 0.88
High prevalence of nonalcoholic fatty liver in patients with idiopathic venous thromboembolism. World J Gastroenterol (2010) 0.88
Bleeding and thrombosis in multiple myeloma and related plasma cell disorders. Semin Thromb Hemost (2011) 0.88
Enteropathic spondyloarthritis: from diagnosis to treatment. Clin Dev Immunol (2013) 0.87
Safety and efficacy of barbed suture for gastrointestinal suture: a prospective and randomized study on obese patients undergoing gastric bypass. J Laparoendosc Adv Surg Tech A (2013) 0.87
Sex differences in patients receiving anticoagulant therapy for venous thromboembolism. Medicine (Baltimore) (2014) 0.86
Relation of flow-mediated dilation to global arterial load: impact of hypertension and additional cardiovascular risk factors. Int J Cardiol (2010) 0.86
Oxidative stress and nitric oxide pathway in adult patients who are candidates for cardiac surgery: patterns and differences. Interact Cardiovasc Thorac Surg (2013) 0.86
What does irritable bowel syndrome share with non-alcoholic fatty liver disease? World J Gastroenterol (2013) 0.85
Diffuse idiopathic skeletal hyperostosis prevalence in subjects with severe atherosclerotic cardiovascular diseases. Arthritis Care Res (Hoboken) (2012) 0.85
Side effects of TNF-α blockers in patients with psoriatic arthritis: evidences from literature studies. Clin Rheumatol (2013) 0.85
Identifying high-risk individuals for cardiovascular disease: similarities between venous and arterial thrombosis in perspective. A 2011 update. Intern Emerg Med (2011) 0.84
Cardiovascular secondary prevention: patients' knowledge of cardiovascular risk factors and their attitude to reduce the risk burden, and the practice of family doctors. The "Help Your Heart Stay Young" study. Ital Heart J (2004) 0.83
Exploring newer cardioprotective strategies: ω-3 fatty acids in perspective. Thromb Haemost (2010) 0.83
Non-vitamin K oral anticoagulants in patients with pulmonary embolism: a systematic review and meta-analysis of the literature. Intern Emerg Med (2015) 0.82
Prevalence of thyroid autoimmunity in patients with spondyloarthropathies. J Rheumatol (2011) 0.82
Extra-articular manifestations in psoriatic arthritis patients. Clin Rheumatol (2014) 0.82
Cardiovascular risk factors and outcome in patients with retinal vein occlusion. J Thromb Thrombolysis (2010) 0.82
Markers of cardiovascular risk in patients with antiphospholipid syndrome: a meta-analysis of literature studies. Ann Med (2014) 0.81
TNF-α blockers and carotid intima-media thickness: an emerging issue in the treatment of psoriatic arthritis. Intern Emerg Med (2011) 0.81
Mesoglycan: clinical evidences for use in vascular diseases. Int J Vasc Med (2010) 0.80
Budd-Chiari syndrome in a paroxysmal nocturnal hemoglobinuria patient with previous cerebral venous thrombosis. Intern Emerg Med (2008) 0.79
Prevention of nephrotoxicity induced by cyclosporine-A: role of antioxidants. J Cell Biochem (2015) 0.79
Predisposing factors in patients with early-onset cerebral vein thrombosis. Thromb Res (2004) 0.78
Non-O blood group as a risk factor for cerebral vein thrombosis. Thromb Haemost (2013) 0.78
Could high levels of tissue polypeptide specific antigen, a marker of apoptosis detected in nonalcoholic steatohepatitis, improve after weight loss? Dis Markers (2009) 0.77
Antithrombin levels and the risk of a first episode of venous thromboembolism: a case-control study. Thromb Haemost (2012) 0.77
Is the quality of life always depressed in patients with chronic hepatitis C on antiviral therapy? Eur J Gastroenterol Hepatol (2005) 0.77
Noninvasive assessment of liver fibrosis in patients with chronic hepatitis C (and congenital bleeding disorders): where do we stand? Semin Thromb Hemost (2013) 0.77
Ultrasound-guided transversus abdominis plane block for retroperitoneal varicocele repair. Could it be an anesthesia method? Updates Surg (2013) 0.77
Recombinant factor VIIa in a patient with Glanzmann's thrombasthenia undergoing gynecological surgery: open issues in light of successful treatment. Thromb Haemost (2004) 0.76
Recombinant activated factor VII (eptacog alfa activated, NovoSeven ® ) in patients with rare congenital bleeding disorders. A systematic review on its use in surgical procedures. Curr Pharm Des (2016) 0.76
Acute coronary syndrome and severe haemophilia: an unusual association with challenging treatment. Thromb Haemost (2010) 0.76
[Venous thromboembolism in oncologic patients: guidelines for prevention and therapy and areas of uncertainty]. Tumori (2007) 0.76
Urinary excretion of iPF(2α)-III predicts the risk of future thrombotic events. A 10-year follow-up. Thromb Res (2011) 0.75
The real effectiveness of ultrasound guidance in subclavian venous access. Ann Ital Chir (2011) 0.75
Reduced in vivo oxidative stress following 5-methyltetrahydrofolate supplementation in patients with early-onset thrombosis and 677TT methylenetetrahydrofolate reductase genotype. Br J Haematol (2005) 0.75
Recent venous thromboembolism amongst adult individuals attending general practitioner ambulatory (the FAST study): prevalence of cardiovascular risk factors. Thromb Res (2008) 0.75
Diagnostic value of abdominal free air detection on a plain chest radiograph in the early postoperative period: a prospective study in 648 consecutive patients who have undergone abdominal surgery. J Gastrointest Surg (2013) 0.75
Pelvic adhesion and gonadotropin-releasing hormone analogue: effects of triptorelin acetate depot on coagulation and fibrinolytic activities. Reprod Sci (2012) 0.75
The "antiphospholipid triangle" in an asymptomatic patient: a case report. Intern Emerg Med (2010) 0.75
Clinical judgment when using coagulation tests during direct oral anticoagulant treatment: a concise review. Semin Thromb Hemost (2013) 0.75
The use of interferon-alpha in a small cohort of patients with a type of idiopathic pulmonary fibrosis, probably post-cryoglobulinaemia, hepatitis C virus related. Eur J Gastroenterol Hepatol (2005) 0.75
Right-to-left shunt, atrial septal aneurysm and thrombophilia in patients with cryptogenic stroke or TIA vs. those with venous thrombo-embolism. Int J Cardiol (2007) 0.75
Efficacy and safety of extended thromboprophylaxis for medically ill patients. A meta-analysis of randomised controlled trials. Thromb Haemost (2017) 0.75
Effectiveness of a rehabilitative programme in improving fatigue and function in rheumatoid arthritis patients treated with biologics: a pilot study. Clin Exp Rheumatol (2013) 0.75